Swertia chirayita
100 and 200 mg/kg,
orally
Female swiss albino mice,
paracetamol-induced hepatotoxicity
Due to free radical scavenging activity
Nagalekshmi et al.
(2011)
Taraxacum
officinale
500 mg/kg, i.p.
Male Wistar rats, sodium dichromate-
induced liver injury
Due to the antioxidant properties of the
phytochemical constituents present in the
extract
Hfaiedh et al. (2016)
Terminalia arjuna
1, 5, 10, 25, 50 mg
and 100 mg/kg, orally
Swiss albino mice, CCl4-induced
hepatotoxicity
The extract exhibits potent antioxidant
activity, thereby protects the liver and
kidney via alteration of cytochrome P450
Manna et al. (2006)
Tragopogon
porrifolius
50 and 250 mg/kg, i.
p.
Male Wistar rats, CCl4-induced
hepatotoxicity
Due to the antioxidant activity of high
contents of phenols and flavonoids present
in the extract
Tenkerian et al.
(2015)
Cleome viscosa
(Cliv-92)
100 and 200 mg/kg,
orally
Albino rats (Druckrey strain), CCl4-
induced hepatotoxicity
Might be due to the interference of
compounds with cytochrome P450, which
results in the interference in the formation
of free radicals and thereby protecting the
integrity of the membranes
Gupta and Dixit
(2009)
Oleanolic acid
20, 40, 80 mg/kg, s.c.
Male Balb/c mice, concanavalin
A-induced liver damage
Through the activation of PPARα,
inhibiting the apoptosis and autophagy
through inhibition of JNK signalling
Wang et al. (2018)
Ursolic acid
5, 10, 20 mg/kg,
orally
Druckrey rats, paracetamol-induced
hepatotoxicity
May be due to its stabilizing effect on
plasma membrane
Shukla et al. (1992)
Berberine
80, 120 and 160 mg/
kg, orally
Male Sprague-Dawley rats, CCl4-
induced hepatotoxicity
Preventive and curative effects of
berberine
Feng et al. (2010)
Naringenin
50 mg/kg, orally
Swiss male mice, CCl4-induced
hepatotoxicity
Due to its ability to scavenge free radicals
Hermenean et al.
(2014)
Proanthocyanidins
10 and 50 mg/kg,
orally;
100 mg/kg, orally
Male Sprague-Dawley rats, ethanol-
induced hepatotoxicity
Male Wistar rats, cadmium-induced
hepatotoxicity
By directly scavenging ROS, regulating
ADH and ALDH enzymes and inhibiting
CYP2E1 expression;
Increase the aerobic capacity of muscle
tissue and improve the mitochondrial
function
Miltonprabu and
Manoharan (2016),
Bak et al. (2016)
(continued)
29
The Pathophysiology of Liver Disorders and Pharmacotherapy Options with. . .
555